mRNA: From a chemical blueprint for protein production to an off-the-shelf therapeutic.
about
Current status and perspectives of immune-based therapies for hepatocellular carcinomamRNA capping: biological functions and applicationsIntranasal mRNA nanoparticle vaccination induces prophylactic and therapeutic anti-tumor immunityImmunotherapeutic approaches for hepatocellular carcinomaCCL21 Cancer Immunotherapy.Particle-mediated Intravenous Delivery of Antigen mRNA Results in Strong Antigen-specific T-cell Responses Despite the Induction of Type I InterferonA development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs
P2860
Q26772326-459CA538-92B8-4592-BC86-8542066DB110Q27469050-E0D42D64-FA50-4E94-A5CA-CB33732FEF73Q33708572-307DF5D7-6E42-494E-96F1-499CC00F0017Q33779723-BBA7F229-DAFF-4F97-90C2-D68DD106198EQ33820300-E3147237-47B5-47F5-97F2-1F12DE0DF902Q37254639-D2FDDE13-6D10-468F-9BFA-B66C46AED79AQ38206520-D00B57E1-5070-4629-AA56-800389E06A31
P2860
mRNA: From a chemical blueprint for protein production to an off-the-shelf therapeutic.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
mRNA: From a chemical blueprint for protein production to an off-the-shelf therapeutic.
@en
type
label
mRNA: From a chemical blueprint for protein production to an off-the-shelf therapeutic.
@en
altLabel
mRNA: From a chemical blueprint for protein production to an off-the-shelf therapeutic
@en
prefLabel
mRNA: From a chemical blueprint for protein production to an off-the-shelf therapeutic.
@en
P2093
P2860
P921
P356
P1476
mRNA: From a chemical blueprint for protein production to an off-the-shelf therapeutic
@en
P2093
Carlo Heirman
Kris Thielemans
Sandra Van Lint
P2860
P304
P356
10.4161/HV.22661
P407
P577
2013-01-04T00:00:00Z